MedPath

Effect of Goal-directed Hemodynamic Therapy on Short-term Postoperative Complications in Patients With Extensive Burns

Not Applicable
Completed
Conditions
Hemodynamics
Registration Number
NCT05221788
Lead Sponsor
Guangzhou Red Cross Hospital
Brief Summary

To investigate the effect of goal-directed hemodynamic management on perfusion and short-term prognosis of patients undergoing scab grafting in early stage of extensive burns.

Detailed Description

Objective: To investigate the effect of goal-directed hemodynamic management on perfusion and short-term prognosis of patients undergoing scab grafting in early stage of extensive burns.

Methods: Ninety-five patients with extensive burns undergoing early debridement grafting were randomly divided into a standard hemodynamic management group (control group) and a goal-directed hemodynamic therapy group (GDHT group), with the control group guided by conventional parameters and the GDHT group guided by SV based on Vigileo. The primary outcome were incidence of cardiac complications, pulmonary complications, neurological disease, acute kidney injury, and pain within 7 days postoperatively. Secondary outcome included microcirculatory perfusion metrics: Lactate (lac), The central venous-arterial carbon dioxide partial pressure difference (Pcv-aCO2).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. the age is between 18 and 65 years old;
  2. the burn area ≥ 50% total burn surface area (TBSA) or the third degree wound area ≥ 20% TBSA;
  3. patients will undergo the first operation after fluid resuscitation (after the shock period). The types of operation include incision decompression, escharectomy and skin grafting, and so on.
Exclusion Criteria
  1. Severe cardiac or pulmonary disease prior to the burn injury, combined with severe internal organ damage.
  2. Patients or family members refusing informed consent for this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Incidence of pulmonary complicationswithin 7 days postoperatively

Incidence of pulmonary complications (pneumonia, pulmonary edema, pleural effusion, oxygenation index \<300)

Incidence of cardiac complicationswithin 7 days postoperatively

Incidence of cardiac complications within 7 days of surgery (myocardial infarction (electrocardiogram (ECG) and/or troponin T serum concentration; new-onset atrial fibrillation)

postoperative pain conditionswithin 7 days postoperatively

postoperative pain

Incidence of neurological complicationswithin 7 days postoperatively

Incidence of Neurological Disorders within 7 days postoperatively (Stroke and Delirium)

Incidence of acute kidney injurywithin 7 days postoperatively

defined by acute kidney injury criteria.

Secondary Outcome Measures
NameTimeMethod
Blood lactate7 days after operation

an indicator related to microcirculation perfusion

Blood lacate2 hours into the operation (T3)

an indicator related to microcirculation perfusion

The central venous-arterial carbon dioxide partial pressure difference (Pcv-aCO2)7 days after operation

an indicator related to microcirculation perfusion

Trial Locations

Locations (1)

Guangzhou RedCross Hospital

🇨🇳

Guanzhou, Guangdong, China

Guangzhou RedCross Hospital
🇨🇳Guanzhou, Guangdong, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.